Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn - Haleon was formed in 2019 by the merger of the consumer ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in ...

Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) ...

(Reuters) -Haleon plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

To buy additional 33% stake for $637 mln Will have option to buy out remaining 12% stake Deal 'strategically and commercially' compelling -CEO Sept 27 (Reuters) - Haleon (HLN.L), opens new tab ...

US drugs giant Pfizer has sold a stake in Sensodyne and Panadol maker Haleon worth around £2.4 billion (Alamy/PA) US drugs giant Pfizer has sold a stake in Sensodyne and Panadol maker Haleon ...

By Shanima A (Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and ...

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in ...